Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Long-Term Investments: 2014-2022

Historic Long-Term Investments for HUTCHMED (China) (HCM) over the last 9 years, with Dec 2022 value amounting to $73.8 million.

  • HUTCHMED (China)'s Long-Term Investments fell 95.47% to $3.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.6 million, marking a year-over-year decrease of 95.47%. This contributed to the annual value of $73.8 million for FY2022, which is 3.53% down from last year.
  • Latest data reveals that HUTCHMED (China) reported Long-Term Investments of $73.8 million as of FY2022, which was down 3.53% from $76.5 million recorded in FY2021.
  • Over the past 5 years, HUTCHMED (China)'s Long-Term Investments peaked at $139.5 million during FY2020, and registered a low of $73.8 million during FY2022.
  • For the 3-year period, HUTCHMED (China)'s Long-Term Investments averaged around $96.6 million, with its median value being $76.5 million (2021).
  • In the last 5 years, HUTCHMED (China)'s Long-Term Investments soared by 40.99% in 2020 and then tumbled by 45.18% in 2021.
  • HUTCHMED (China)'s Long-Term Investments (Yearly) stood at $138.3 million in 2018, then fell by 28.47% to $98.9 million in 2019, then spiked by 40.99% to $139.5 million in 2020, then tumbled by 45.18% to $76.5 million in 2021, then dropped by 3.53% to $73.8 million in 2022.